Stemtech Corporation (STEK)
OID · Healthcare · Drug Manufacturers - Specialty & Generic
Closing price as of 2026-07-29 · Source: TEK2day Finance
Key Metrics
About Stemtech Corporation
Stemtech Corporation, a stem cell nutrition company, develops science-based products to help the body maintain healthy stem cell physiology in the Americas, Latin America, and Asia. The company's products enhance and support the work of the body's stem cells by releasing more stem cells, helping to circulate them in the blood, and migrate them into tissues, where they can perform their daily function of renewal for optimal health. It offers rapid renew stem cell peptide night cream under the RCM System, stemrelease3, Stemflo MigraStem, OraStem, and Collect One brand name, as well as Cellect One shield hypochlorous acid skin care product. It serves through independent distributors Stemtech Corporation was founded in 2005 and is headquartered in Naples, Florida.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 698K | 852K | 458K | 463K |
| Gross Profit | 552K | 682K | 355K | 354K |
| Operating Income | -301K | -339K | -864K | -1.1M |
| Net Income | -293K | -809K | -1.5M | -1.3M |
| Diluted EPS | $0.00 | $-0.01 | $nan | $0.00 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 4.6M | 4.9M | 5.1M | 2.9M |
| Gross Profit | 3.4M | 3.9M | 3.7M | 2.3M |
| Operating Income | -5.0M | -4.2M | -2.4M | -2.7M |
| Net Income | -8.5M | -5.4M | -3.8M | -4.0M |
| Diluted EPS | $-0.19 | $-0.07 | $-0.03 | $nan |